Delivery Order SPE2DB22D2206-SPE2DB25FKB10
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,495.01 to AmerisourceBergen Drug Corp for Medroxyprogesterone 150 mg/mL, a progestin medication used in hormone replacement therapy and contraceptive applications. The contract, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,123.41 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a synthetic progestin used in hormone therapy and contraceptive applications. This firm fixed-price contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,945.38 to AmerisourceBergen Drug Corp for Medroxyprogesterone, a synthetic progestin commonly used in hormone therapy and contraceptive applications. Issued on August 20, 2025, with an ultimate completion date of August 21, 2025, this firm fixed-price contract represents a non-competitive, non-set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,003.18 delivery order to AmerisourceBergen Drug Corp for medroxyprogesterone on September 13, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement executed under the company's existing contract vehicle. The work will be performed at the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.15 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone-based pharmaceutical product. This non-competitive delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,839.57 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/ml. This competitive award, issued on September 4, 2025, carries a firm fixed price structure with performance completion targeted for September 5, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a $12,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day contract spanning August 24-25, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $731.60 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The firm fixed price contract has a period of performance from July 11, 2023 through July 12, 2023 and will be performed in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract...
- The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.14 firm fixed-price delivery order is for the supply of MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product, with a period of performance through March 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at approximately $737 to Amerisourcebergen Drug Corporation for the provision of 150 mg/ml medroxyprogesterone. The firm fixed price order is being carried out under the Prime Vendor Program, with performance taking place in Conshohocken, Pennsylvania from August 11-14, 2023. As a leading provider of pharmaceuticals and healthcare products to the DOD, Amerisourcebergen will deliver the contracted contraceptive supplies to support...